CClinicalTrials.gg
Not yet recruitingNCT06239922Updated Feb 2, 2024

Cognitive and Neural Assessment Platform and Localized Norm for Macau Older Adults.

An observational study in Cognition Disorders in Old Age, Cognitive Decline and Cognitive Impairment, sponsored by University of Macau. Not yet recruiting at 1 site in Macau. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-02.

Sponsored by University of Macau · Observational

From the registry’s dates

  • Primary completion was expected by Mar 2026, 6 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Ecologic or community
Time perspective
Prospective
Enrollment
300
Ages
18 Years and older
Sex
All
01

Study summary

The current project is dedicated to creating a comprehensive cognitive and neural assessment platform and corresponding norms tailored specifically to the older adults in Macau.

Read the detailed description

The investigators will establish this assessment platform using a combination of methods, including interviews, surveys, and expert reviews.

Steps include adapting existing assessment methods to the Macau context, developing new cognitive and neural tasks, defining standardized procedures, seeking external expert input, conducting pilot tests, and validation processes, and refining both the platform and its accompanying manual.

02

Conditions studied

  • Cognition Disorders in Old Age
  • Cognitive Decline
  • Cognitive Impairment
  • Cognitive Dysfunction
  • Cognitive Change
  • Aging

Keywords

  • Macau
  • cognitive aging
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's planned enrollment of 300 is above the median of 150 across 950 observational studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

University of Macau is the lead sponsor of 14 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults above 50 years old from the Macau local community.

Inclusion criteria

  • Must be a local adult resident of Macau
  • Age above 50 years for older adult cohort
  • Younger adults individuals above 18 will be included as control comparators

Exclusion criteria

Exclusion Criteria:

  • History of neurological injury or disease
  • Current use of medications that affect brain function or blood flow
  • Contraindications to MRI scanning, such as the presence of an electric/mechanical implant or device (e.g., pacemaker)
  • Claustrophobia
  • Body weight over 300 lbs due to weight and physical constraints of the scanner (i.e., bore size limited to 55 cm)
  • Inability to provide informed consent
  • Pregnancy
  • Being under the legal age of adulthood (children)
  • Incarcerated individuals (prisoners)
05

Study design

Observational model
Ecologic or community
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Group 1

    Older adults

  • Group 2

    Younger adults

06

What researchers measure

Primary outcomes

  1. Normative Data for the Montreal Cognitive Assessment - Chinese (Hong Kong) version

    The MoCA will be administered to derive a normative data set representative of the older adult population in Macau.

    Time frame: From February 2024 to January 2026

  2. Normative Data for the Mini-Mental State Examination (MMSE)

    The MMSE will be administered to derive a normative data set representative of the older adult population in Macau.

    Time frame: From February 2024 to January 2026

  3. Normative Scores for Computerized Neuropsychological Tasks

    Neuropsychological tasks will be employed to measure selective attention capacity and processing speed in the study cohort. These tasks will provide quantifiable data on the efficiency and accuracy of cognitive processing. The collective performance on these tasks will be used to establish benchmark values - including means, medians, and ranges - that define the normative standards for these cognitive abilities in the population.

    Time frame: From February 2024 to January 2026

Secondary outcomes

  1. Neural Activation Patterns During Cognitive Tasks as Revealed by Functional Magnetic Resonance Imaging (fMRI)

    fMRI data will be collected to identify patterns of neural activation associated with cognitive task performance.

    Time frame: From February 2024 to January 2026

  2. Cerebral Hemodynamics Assessed Through Functional Near-Infrared Spectroscopy (fNIRS)

    fNIRS will be employed to measure cerebral blood flow and oxygenation during cognitive tasks.

    Time frame: From February 2024 to January 2026

  3. Electrophysiological Correlates of Cognitive Activity as Measured by Electroencephalography (EEG)

    EEG will be utilized to record the electrical activity of the brain during cognitive tasks. Key outcome metrics will include event-related potentials (ERPs) amplitudes and latencies, with mean values and variability measures reported for the cohort.

    Time frame: From February 2024 to January 2026

07

Study locations

1 site
  • Centre for Cognitive and Brain Sciences of the University of Macau
    Macao, Macao SAR 999078, Macau
    • Haoyun ZHANG Assistant Professor · Contact · haoyunzhang@um.edu.mo · +853 88229212
    • LEI KEI KEI Research Assistant, MSc · Contact · keikeilei@umac.mo · +853 8822 9198
    • Haoyun ZHANG Assistant Professor, Ph.D · Principal investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06239922
Lead sponsor
University of Macau
Responsible party
Sponsor
First posted
Feb 2, 2024
Start date
Feb 2024 (estimated)
Primary completion
Mar 30, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Feb 2, 2024

Study contacts

Haoyun ZHANG Assistant Professor
Contact
haoyunzhang@um.edu.mo
+853 88229212
LEI KEI KEI research assistant, MSc
Contact
keikeilei@umac.mo
+853 88229198
Haoyun ZHANG Assistant Professor, Ph.D
principal investigator · University of Macau

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jan 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion